RETRACTED: The biopharmaceutical classification of medicinal substances
Abstract
The goal of this investigation is to describe the main types of medicines (b(biopharmaceutical classification system (BCS) and biopharmaceutic classification of drugs according to their solubility and metabolism (BDDCS). The methods of evaluation of biopharmaceutical properties (solubility and permeability) of medical substances are under consideration. The applicability of these systems in the evaluation interchange is viewed in relation to generic substances in vitro (procedure «bioveyver»).
About the Authors
G. V. Ramenskaya
First MSMU named after I. M. Sechenov
Russian Federation
Russian Federation
Doctor of pharmacy, prof., head of the chair of pharmaceutical chemistry with a course of toxicological chemistry
I. E. Shokhin
First MSMU named after I. M. Sechenov
Russian Federation
Russian Federation
PhD, assistant of the chair of pharmaceutical chemistry with a course of toxicological chemistry
Yu. I. Kulinich
First MSMU named after I. M. Sechenov
Russian Federation
Russian Federation
post-graduate student of the chair of pharmaceutical chemistry with a course of toxicological chemistry
References
1. Раменская Г.В., Шохин И.Е., Савченко А.Ю. и соавт. Процедура «биовейвер»: современные подходы и общие рекомендации для оценки эквивалентности in vitro лекарственных средств немедленного высвобождения // Рецепт. 2010. № 5: С. 33–39.
2. Proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release solid oral dosage forms. Technical Report Series, No 937, 40th Report, Annex 8 of WHO Expert Committee on Specifications for Preparations. WHO, 2006.
3. Guidance for Industry: Waiver of in vivo Bioavailability and Bio-equivalence Studies for Immediate Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification. FDA, 2000.
4. Методические рекомендации Росздравнадзора для разработчиков и производителей лекарственных средств по оценке эквивалентности in vitro генерических лекарственных средств согласно процедуре «биовейвер» / Росздравнадзор, 2010.
5. Lindenberg M., Kopp S., Dressman J. Classification of orally administrated drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 2004; 58: 265–278.
6. Перечень жизненно необходимых и важнейших лекарственных средств (ЖНВЛС): Распоряжение Правительства РФ № 2135-р [Утв. от 30.12.2009]
7. Dressman J., Lennernäs H. Oral Drug Absorption: prediction and assessment. New York: CRC Press, 2000.
8. Kasim N.A., Whitehouse M., Ramachandran C. et al. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol. Pharm. 2004; 1: 85–96.
9. Hilfinger J. Permeability Classification. In vitro and in situ methodology. URL: http://www.aapspharmaceutica.com/meetings/files/90/13Hilfinger.pdf (2010, 10 дек.).
10. Wu C.-Y., Benet L. Predicting Drug Disposition via Application of BCS: Transport/ Absorption / Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System. Pharm. Res. 2005; 1: 11–23.
11. Shohin I.E., Ramenskaya G.V., Vasilenko G.F., Malashenko E.A. In vitro dissolution kinetics of amlodipine tablets marketed in Russia under biowaiver conditions. Diss. Tech. 2010; 3: 20–22.
Review
Views:
672
Email this article 